Inhaled fluticasone furoate/vilanterol does not affect hypothalamic-pituitary-adrenal axis function in adolescent and adult asthma: randomised, double-blind, placebo-controlled study

INTRODUCTION: Fluticasone furoate (FF) is a novel inhaled corticosteroid with 24-h activity. FF is in development as a once-daily treatment for asthma as monotherapy and in combination with vilanterol (VI), a long-acting β(2) agonist. Corticosteroids can have systemic effects on hypothalamic-pituita...

Descripción completa

Detalles Bibliográficos
Autores principales: Allen, Ann, Schenkenberger, Isabelle, Trivedi, Roopa, Cole, Jeremy, Hicks, Wesley, Gul, Nadeem, Jacques, Loretta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352333/
https://www.ncbi.nlm.nih.gov/pubmed/23578031
http://dx.doi.org/10.1111/crj.12026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352333/
https://www.ncbi.nlm.nih.gov/pubmed/23578031
http://dx.doi.org/10.1111/crj.12026

Ejemplares similares